GlassScriptPhysician profile
Karla Rubini
NPI 1093366551
$854.24
in general payments reported to CMS, 2019-2025
14 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.45 · 2022: $203 · 2023: $249 · 2024: $204 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $174.26 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $101.06 | 2021-2024 | |
| Kaleo, INC. | $89.87 | 2022-2024 | Auvi-Q |
| Tris Pharma INC | $86.89 | 2022 | |
| Pfizer INC. | $81.17 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $67.64 | 2024-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $58.97 | 2023-2024 | Jornay Pm |
| Hologic Sales and Service, LLC | $37.05 | 2024-2025 | Aptima |
| Alk-Abello, INC | $35.86 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $32.98 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $29.71 | 2022-2023 | Flucelvax Quadrivalent |
| Adlon Therapeutics L.P. | $26.11 | 2021 | |
| Cranial Technologies, INC | $17.96 | 2025 | Doc Band |
| Phadia US INC. | $14.71 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Rubini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.